PenderFund Capital Management Ltd.
Source: SEC Form 13F · as of Mar 2026PenderFund Capital Management Ltd. holds 5 biotech & pharma companies tracked by BioSniper, totaling $12.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
5
Total value held
$12.1M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Esperion Therapeutics, Inc. (ESPR)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ESPREsperion Therapeutics, Inc. | 3,891,926 | $10.7M |
| FOLDAMICUS THERAPEUTICS, INC. | 41,100 | $594K |
| DAWNDay One Biopharmaceuticals, Inc. | 26,800 | $575K |
| LSTALISATA THERAPEUTICS, INC. | 47,500 | $238K |
| RNAAtrium Therapeutics Inc. | 490 | $7K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.